Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE We found that both the heterozygous CT (adjusted OR = 0.78, 95% CI: 0.67-0.92) and the homozygous TT genotypes (adjusted OR = 0.68, 95% CI: 0.55-0.83) of c.677C>T were associated with a significantly decreased risk of PCa compared with homozygous wild-type CC genotype, respectively, using multivariate logistic regression. 27819322

2016

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE Taken together, the existing evidence indicates the homozygote TT of MTHFR C677T should be viewed as a protective factor against PCa risk for clinical practice with the consideration of different gene background, study design as well as specific controls. 25841988

2015

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE The C677T CT polymorphism of MTHFR may be a risk factor for prostate cancer in East Asians. 26782572

2015

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE These results suggest that the MTHFR C677T polymorphism does not contribute to the risk of prostate cancer from currently available evidence in populations overall and Caucasians. 26107198

2015

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE Using conditional logistic regression, odds ratios (OR) and 95% confidence intervals (CI) for prostate cancer risk were estimated according to quintiles of serum folate, vitamin B12, methylmalonic acid (MMA), total homocysteine (tHcy) and methionine, and according to MTHFR 677C→T genotypes. 23508410

2013

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE The MTHFR C677T polymorphism has significant effects on susceptibility to prostate cancer in Ecuadorian population, especially with the Gleason grade. 23459165

2013

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE C677T of the MTHFR gene may provide protective effects on susceptibility to prostate cancer risk. 22370724

2012

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls. 22938427

2012

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE Effects of the MTHFR C677T polymorphism on prostate specific antigen and prostate cancer. 22296369

2011

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE Our results provide the first evidence that the C allele of MTHFR C677T may be associated with the development of prostate cancer and may be a novel useful marker for primary prevention and anticancer intervention. 20944139

2010

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE This meta-analysis supports that the C677T of the MTHFR gene is a low-penetrance susceptibility gene for prostate cancer, and might provide protective effects against prostate cancer risk. 19223177

2009

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE In this study, it has been observed that C677T polymorphism of the MTHFR gene produces no statistically significant difference for T allele frequency and the genotype frequency in prostate cancer patients and male controls with benign prostate hyperplasia not having prostate cancer, whereas it has been observed that A1298C polymorphism produces a statistically significant difference for C allele frequency in prostate cancer patients and controls and that it also produces a statistically marginal significance for genotype frequencies. 19814618

2009

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE Our data indicate that the C677T MTHFR polymorphism does not significantly contribute to the inherited genetic susceptibility to breast and prostate cancer, while we show some evidence for possible genetic contribution of this polymorphism to the development of head and neck carcinoma. 17573062

2007

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE In conclusion, our results do not provide strong support for the hypothesis that the MTHFR 677C-->T polymorphism is related to prostate cancer risk. 17846906

2007

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE We found that the MTHFR 677C-->T polymorphism is not likely to have a major role in the development of prostate cancer, although it may possibly increase the risk in combination with high plasma folate levels. 16374229

2006

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE Among all study subjects, we observed no association between the C677T variant and prostate cancer but a slight positive association between the A1298C variant and risk of this disease [odds ratio (OR) 1.41, 95% confidence interval (CI) 0.96-2.06; P = 0.08]. 15298954

2004